1. Home
  2. PRE vs ACRS Comparison

PRE vs ACRS Comparison

Compare PRE & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prenetics Global Limited

PRE

Prenetics Global Limited

N/A

Current Price

$21.26

Market Cap

337.6M

Sector

Industrials

ML Signal

N/A

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

N/A

Current Price

$4.48

Market Cap

311.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRE
ACRS
Founded
2014
2012
Country
Hong Kong
United States
Employees
98
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
337.6M
311.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PRE
ACRS
Price
$21.26
$4.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$30.50
$10.20
AVG Volume (30 Days)
299.1K
1.1M
Earning Date
06-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.01
EPS
N/A
N/A
Revenue
N/A
$1,683,000.00
Revenue This Year
$108.69
N/A
Revenue Next Year
$58.68
$4.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.01
$1.34
52 Week High
$23.63
$5.15

Technical Indicators

Market Signals
Indicator
PRE
ACRS
Relative Strength Index (RSI) 58.51 51.61
Support Level $12.92 $4.15
Resistance Level $21.72 $4.73
Average True Range (ATR) 1.86 0.24
MACD 0.17 -0.03
Stochastic Oscillator 77.81 60.48

Price Performance

Historical Comparison
PRE
ACRS

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: